10
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Call for Papers: Digital Platforms and Artificial Intelligence in Dementia

      Submit here by August 31, 2025

      About Dementia and Geriatric Cognitive Disorders: 2.2 Impact Factor I 4.7 CiteScore I 0.809 Scimago Journal & Country Rank (SJR)

      Call for Papers: Skin Health in Aging Populations

      Submit here by August 31, 2025

      About Skin Pharmacology and Physiology: 2.8 Impact Factor I 5.2 CiteScore I 0.623 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients

      research-article
      a , * , b , c , d , a , e , e , f , f , g , h , i , j , k , l , m , n , o , p , q , r , s , t , u , v , w , b , a
      Dermatology
      S. Karger AG
      Mycosis fungoides, Childhood, Primitive cutaneous lymphoma

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Our objective was to describe the clinical, histological characteristics, and disease outcome of a cohort of mycosis fungoides (MF) diagnosed during childhood including disease status at adulthood. Methods: This is a retrospective multicentre survey of patients aged under 18 years at diagnosis with histologically confirmed MF. Patients’ clinical and histological characteristics, treatments, and disease outcome (for patients followed for more than 12 months) were analysed. Results: Forty-six patients were included (median age at diagnosis: 11 years; M:F sex ratio: 3:1) with 39 (85%) followed for at least 12 months. Thirty-nine patients (85%) had stage I MF. Hypopigmented patches were observed in 48% and folliculotropism in 43% patients. Immunophenotype of the skin infiltrate was predominantly CD8+ in 17% of patients. Initial management included a wait-and-see strategy in 6/39 (15%), skin-directed treatment in 27 (69%), and systemic treatment in 6 (15%) patients, respectively, with partial or complete clinical response (PR or CR) observed in 28 patients (72%). 14/39 patients (36%) relapsed after initial response. After a median follow-up period of 54 months, disease status at last news was PR or CR in 31/39 (79%), stable disease in 6 (15%), and progression in 2 (5%) patients. Histological transformation was observed in 3/39 (8%). Of the 15 patients followed until adulthood, 13 (87%) had persistent MF. Discussion: This survey confirms the high frequency of hypopigmented and folliculotropic lesions and of CD8+ immunophenotype compared to adult MF patients. The long-term course is usually indolent but transformation may occur sometimes long after disease onset and the disease may persist during adulthood.

          Related collections

          Author and article information

          Journal
          DRM
          Dermatology
          10.1159/issn.1018-8665
          Dermatology
          Dermatology
          S. Karger AG
          1018-8665
          1421-9832
          2023
          January 2023
          04 November 2022
          : 239
          : 1
          : 132-139
          Affiliations
          [_a] aDepartment of Dermatology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France
          [_b] bDepartment of Dermatology, University of Montpellier and INSERM U1058, Montpellier, France
          [_c] cDepartment of Pathology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France
          [_d] dDepartment of Pathology, CHU de Montpellier, Montpellier, France
          [_e] eDepartment of Dermatology, CHU de Nice, Université Nice Côte d’Azur, Nice, France
          [_f] fDepartment of Dermatology, Hospital Saint Louis, APHP. Université de Paris, INSERM UMR 976, Paris, France
          [_g] gDepartment of Pathology, Hospital Saint Louis, APHP. Université de Paris, Paris, France
          [_h] hDepartment of Dermatology, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France
          [_i] iDepartment of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France
          [_j] jDepartment of Dermatology, Hospital la Timone, Université Aix-Marseille, Assistance Publique des Hôpitaux de Marseille, Marseille, France
          [_k] kDepartment of Dermatology, CHU de Bordeaux, INSERM U1053 Oncogenèse des lymphomes cutanés, Université de Bordeaux, Bordeaux, France
          [_l] lDepartment of Pathology, CHU de Bordeaux, INSERM U1053 Oncogenèse des lymphomes cutanés, Université de Bordeaux, Bordeaux, France
          [_m] mDepartment of Dermatology, CHU de Toulouse, Université Toulouse III, Toulouse, France
          [_n] nDepartment of Dermatology, CHU de Rouen, Rouen, France
          [_o] oDepartment of Dermatology, Hotel Dieu, CHU de Nantes, Nantes, France
          [_p] pDepartment of Dermatology, Hospital Claude Huriez, CHRU Lille, Lille, France
          [_q] qDepartment of Dermatology, CH Valence, Valence, France
          [_r] rDepartment of Hematology, Institut d’hématologie et oncologie pediatrique, Lyon, France
          [_s] sDepartment of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
          [_t] tDepartment of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
          [_u] uDepartment of Dermatology, CHU de Besancon, INSERM UMR 1098, Université de Franche-Comté, Besancon, France
          [_v] vDepartment of Dermatology, CHU Pontchaillou, Rennes, France
          [_w] wDepartment of Dermatology, Hospital Henri Mondor, APHP, University Paris Est Créteil EpiDermE, Creteil, France
          Author notes
          *Christine Bodemer, christine.bodemer@aphp.fr
          Author information
          https://orcid.org/0000-0002-0799-2618
          https://orcid.org/0000-0001-6150-1229
          https://orcid.org/0000-0001-6259-9790
          https://orcid.org/0000-0001-7404-010X
          https://orcid.org/0000-0003-1210-6112
          https://orcid.org/0000-0002-5383-7096
          https://orcid.org/0000-0001-8772-0905
          Article
          526788 Dermatology 2023;239:132–139
          10.1159/000526788
          36349768
          abbf9cb5-5c1f-4d5e-817a-9ead9a1d4fba
          © 2022 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

          History
          : 02 May 2022
          : 21 June 2022
          Page count
          Figures: 1, Tables: 3, Pages: 8
          Funding
          The authors have no funding sources to declare.
          Categories
          Skin Cancer – Research Article

          Medicine
          Primitive cutaneous lymphoma,Childhood,Mycosis fungoides
          Medicine
          Primitive cutaneous lymphoma, Childhood, Mycosis fungoides

          Comments

          Comment on this article

          Related Documents Log